A business in context

STLN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-11-17 · 7996 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4/A · Ownership change

    Report date 2026-11-11 · 0001193805-26-001470

  2. 4 · Ownership change

    Report date 2026-11-11 · 0001193805-26-001455

  3. 8-K/A · Current report

    Report date 2026-11-12 · 0001079973-26-001469 · Items 7.01,9.01

  4. 8-K · Current report

    Report date 2026-11-12 · 0001079973-26-001457 · Items 7.01,9.01

  5. 4 · Ownership change

    Report date 2026-11-06 · 0000921895-26-003018

  6. 10-Q · Quarterly report

    Report date 2026-09-30 · 0001799191-26-000023

  7. 8-K · Current report

    Report date 2026-11-05 · 0001079973-26-001430 · Items 2.02,9.01

  8. 8-K · Current report

    Report date 2026-09-01 · 0001079973-26-001208 · Items 5.02

  9. 4 · Ownership change

    Report date 2026-08-21 · 0001079973-26-001175

  10. 8-K · Current report

    Report date 2026-08-20 · 0001079973-26-001169 · Items 1.01,2.03,9.01

  11. 4 · Ownership change

    Report date 2026-08-13 · 0000921895-26-002203

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001799191-26-000017

  13. 8-K · Current report

    Report date 2026-08-06 · 0001079973-26-001006 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-07-28 · 0001079973-26-000997 · Items 5.03,7.01,9.01

  15. 4 · Ownership change

    Report date 2026-07-27 · 0001079973-26-000993

  16. 4 · Ownership change

    Report date 2026-07-27 · 0001079973-26-000991

  17. 4 · Ownership change

    Report date 2026-07-27 · 0001079973-26-000989

  18. 8-K · Current report

    Report date 2026-07-01 · 0001079973-26-000934 · Items 1.01,2.03,3.02,7.01,9.01

  19. 8-K · Current report

    Report date 2026-06-17 · 0001553350-26-000093 · Items 5.07

  20. 8-K · Current report

    Report date 2026-05-20 · 0001079973-26-000721 · Items 1.05,9.01

  21. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001799191-26-000010

  22. 8-K · Current report

    Report date 2026-05-07 · 0001079973-26-000611 · Items 2.02,9.01

  23. DEF 14A · Proxy statement

    Report date 2026-06-17 · 0001193125-26-197350

  24. 8-K · Current report

    Report date 2026-03-13 · 0001079973-26-000304 · Items 7.01,9.01

  25. 10-K · Annual report

    Report date 2025-12-31 · 0001799191-26-000007

  26. 8-K · Current report

    Report date 2026-03-12 · 0001079973-26-000291 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2026-02-23 · 0001553350-26-000007 · Items 5.02,7.01,9.01

  28. 8-K · Current report

    Report date 2026-01-12 · 0001079973-26-000068 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2026-01-02 · 0001079973-26-000051 · Items 5.02,7.01,9.01

  30. 8-K · Current report

    Report date 2025-11-26 · 0001553350-25-000168 · Items 5.02,7.01,9.01

  31. 8-K · Current report

    Report date 2025-11-14 · 0001079973-25-001724 · Items 7.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001799191-25-000036

  33. 8-K · Current report

    Report date 2025-11-13 · 0001079973-25-001707 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-11-03 · 0001079973-25-001666 · Items 7.01,9.01

  35. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-040225

  36. 8-K · Current report

    Report date 2025-08-13 · 0001079973-25-001264 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-08-08 · 0001079973-25-001263 · Items 5.02,7.01,9.01

  38. 8-K · Current report

    Report date 2025-05-19 · 0001079973-25-000905 · Items 7.01,9.01

  39. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-025507

  40. 8-K · Current report

    Report date 2025-05-14 · 0001079973-25-000800 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-11-14 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 3 transaction rows3PSale: 4 transaction rows4SGrant / award: 9 transaction rows9AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

20 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-21
2026-08-24
Hively Brad
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock298853.06.51
2026-08-14
2026-08-17
Chernett JoreyP · Purchase
Acquired
Common Stock12000.06.54
2026-08-13
2026-08-17
Chernett JoreyS · Sale
Disposed
Call Option (STLN 19FEB27 $9C)
Derivative security
100.06.24
2026-07-27
2026-07-29
Kaushal MohitA · Grant / award
Acquired
Common Stock33133.00.0
2026-07-27
2026-07-29
McGeorge AnneA · Grant / award
Acquired
Common Stock41165.00.0
2026-07-27
2026-07-29
Pacala Mark LA · Grant / award
Acquired
Common Stock30120.00.0
2026-07-27
2026-07-29
STOLPER MARKA · Grant / award
Acquired
Common Stock31124.00.0
2026-07-27
2026-07-29
TZOUMAKAS KIMBERLY JOA · Grant / award
Acquired
Common Stock29116.00.0
2026-07-27
2026-07-29
Hively BradA · Grant / award
Acquired
Common Stock27108.00.0
2026-07-27
2026-07-29
Johnson Karen MarieA · Grant / award
Acquired
Common Stock31124.00.0
2026-07-21
2026-07-22
Chernett JoreyP · Purchase
Acquired
Common Stock18000.05.27
2026-07-14
2026-07-16
Podnos Yale
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock5478.02.0
2026-07-14
2026-07-16
Podnos Yale
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5478.06.35
2026-07-14
2026-07-16
Podnos Yale
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock17974.06.43
2026-07-14
2026-07-16
Podnos Yale
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17974.01.87
2026-07-14
2026-07-16
Podnos Yale
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Stock Option (Right to Buy)
Derivative security
17974.01.87
2026-07-14
2026-07-16
Podnos Yale
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Stock Option (Right to Buy)
Derivative security
5478.02.0
2026-07-10
2026-07-13
Chernett JoreyP · Purchase
Acquired
Common Stock15000.05.85
2026-07-07
2026-07-09
TZOUMAKAS KIMBERLY JOA · Grant / award
Acquired
Common Stock17185.00.0
2026-07-07
2026-07-09
STOLPER MARKA · Grant / award
Acquired
Common Stock25833.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-11-14 · 1656 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001799191Starling Oncology, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-11-14 · 1196 checked identities; 0 unavailable records

Search names and former names
  • Oncology Institute, Inc. · former SEC name · 2021-08-30 to 2026-08-03
  • DFP HEALTHCARE ACQUISITIONS CORP. · former SEC name · 2020-01-14 to 2021-11-12

Revenue in constant purchasing power

USD revenue expressed in 2026-10 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$393.41M$423.28M
2023-12-31$324.24M$359.13M
2022-12-31$252.48M$291.13M
2021-12-31$203.00M$252.81M
2020-12-31$187.51M$244.53M

Bureau of Labor Statistics · retrieved 2026-11-17 · 9 selected series; gaps remain missing

Explore the CPI history ↗